Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Jul;34(7):1456–1458. doi: 10.1128/aac.34.7.1456

Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.

J E Mortensen 1, S L Himes 1
PMCID: PMC176002  PMID: 2386375

Abstract

The in vitro activity of cefixime was comparatively tested against 232 non-type b and 102 type b isolates of Haemophilus influenzae derived from clinical specimens of pediatric patients, including 10 non-type b strains that did not produce beta-lactamase and demonstrated resistance to ampicillin. Cefixime was active against the ampicillin-susceptible and ampicillin-resistant, beta-lactamase-producing isolates; however, its activity against some non-beta-lactamase-producing, ampicillin-resistant isolates appeared to be limited.

Full text

PDF
1456

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bannatyne R. M., Toma S., Cheung R., Hodge D. Antibiotic susceptibility of blood and cerebrospinal fluid isolates of Haemophilus influenzae. J Antimicrob Chemother. 1985 Feb;15(2):187–191. doi: 10.1093/jac/15.2.187. [DOI] [PubMed] [Google Scholar]
  2. Bergeron M. G., Lavoie G. Y., Boucher F. D. Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains. J Antimicrob Chemother. 1987 Nov;20(5):663–669. doi: 10.1093/jac/20.5.663. [DOI] [PubMed] [Google Scholar]
  3. Cullmann W., Dick W., Stieglitz M., Opferkuch W. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance. Chemotherapy. 1988;34(3):202–215. doi: 10.1159/000238572. [DOI] [PubMed] [Google Scholar]
  4. Doern G. V., Jorgensen J. H., Thornsberry C., Preston D. A., Tubert T., Redding J. S., Maher L. A. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother. 1988 Feb;32(2):180–185. doi: 10.1128/aac.32.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fuchs P. C., Barry A. L., Jones R. N. Cefixime disk susceptibility test criteria. J Clin Microbiol. 1986 Oct;24(4):647–649. doi: 10.1128/jcm.24.4.647-649.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fuchs P. C., Jones R. N., Barry A. L., Thornsberry C., Ayers L. W., Gavan T. L., Gerlach E. H. In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria. Diagn Microbiol Infect Dis. 1986 Jul;5(2):151–162. doi: 10.1016/0732-8893(86)90117-3. [DOI] [PubMed] [Google Scholar]
  7. Jorgensen J. H., Doern G. V., Thornsberry C., Preston D. A., Redding J. S., Maher L. A., Tubert T. Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents. Diagn Microbiol Infect Dis. 1988 Jan;9(1):27–32. doi: 10.1016/0732-8893(88)90057-0. [DOI] [PubMed] [Google Scholar]
  8. Jorgensen J. H., Redding J. S., Maher L. A., Howell A. W. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J Clin Microbiol. 1987 Nov;25(11):2105–2113. doi: 10.1128/jcm.25.11.2105-2113.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kamimura T., Kojo H., Matsumoto Y., Mine Y., Goto S., Kuwahara S. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic. Antimicrob Agents Chemother. 1984 Jan;25(1):98–104. doi: 10.1128/aac.25.1.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Khan W., Ross S., Rodriguez W., Controni G., Saz A. K. Haemophilus influenzae type B resistant to ampicillin. A report of two cases. JAMA. 1974 Jul 15;229(3):298–301. [PubMed] [Google Scholar]
  11. Knapp C. C., Sierra-Madero J., Washington J. A. Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone. Antimicrob Agents Chemother. 1988 Dec;32(12):1896–1898. doi: 10.1128/aac.32.12.1896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kumar A., Kelly K. J. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients. Chemotherapy. 1988;34(1):30–35. doi: 10.1159/000238544. [DOI] [PubMed] [Google Scholar]
  13. Mendelman P. M., Chaffin D. O., Musser J. M., De Groot R., Serfass D. A., Selander R. K. Genetic and phenotypic diversity among ampicillin-resistant, non-beta-lactamase-producing, nontypeable Haemophilus influenzae isolates. Infect Immun. 1987 Nov;55(11):2585–2589. doi: 10.1128/iai.55.11.2585-2589.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mendelman P. M., Chaffin D. O., Stull T. L., Rubens C. E., Mack K. D., Smith A. L. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother. 1984 Aug;26(2):235–244. doi: 10.1128/aac.26.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mendelman P. M., Henritzy L. L., Chaffin D. O., Lent K., Smith A. L., Stull T. L., Wiley E. A. In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother. 1989 Nov;33(11):1878–1882. doi: 10.1128/aac.33.11.1878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Powell M., Koutsia-Carouzou C., Voutsinas D., Seymour A., Williams J. D. Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986. Br Med J (Clin Res Ed) 1987 Jul 18;295(6591):176–179. doi: 10.1136/bmj.295.6591.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Powell M., Williams J. D. In vitro susceptibility of Haemophilus influenzae to cefixime. Antimicrob Agents Chemother. 1987 Nov;31(11):1841–1842. doi: 10.1128/aac.31.11.1841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tomeh M. O., Starr S. E., McGowan J. E., Jr, Terry P. M., Nahmias A. J. Ampicillin-resistant Haemophilus influenzae type B infection. JAMA. 1974 Jul 15;229(3):295–297. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES